Idiopathic Small Fiber Neuropathy Completed Phase 2 Trials for Pregabalin (DB00230)

IndicationStatusPhase
DBCOND0077075 (Idiopathic Small Fiber Neuropathy)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02607254Efficacy and Safety of Pregabalin in Treatment of Neuropathic Pain in Patients With Idiopathic Small Fiber NeuropathyTreatment